Serum tenascin-C is an indicator of inflammatory bowel disease activity

International Journal of Colorectal Disease

Volumn 16, Issue 5, 2001, Pages 285-291

  Riedl, S ^a   Tandara, A ^a   Reinshagen, M ^a   Hinz, U ^a   Faissner, A ^a   Bodenmuller H ^a   Buhr, H J ^a   Herfarth, C ^a   Moller P ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Crohn's disease; Disease activity; Inflammatory bowel disease; Tenascin C; Ulcerative colitis

Indexed keywords

ANTIINFLAMMATORY AGENT; AZATHIOPRINE; HYDROCORTISONE; MATRIX PROTEIN; METRONIDAZOLE; SALAZOSULFAPYRIDINE; STEROID; TENASCIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL FEATURE; COLON CROHN DISEASE; COLON MUCOSA; COLON POLYPOSIS; CONCENTRATION (PARAMETERS); CONSERVATIVE TREATMENT; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ACTIVITY; DISEASE COURSE; DISEASE MARKER; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILIAL DISEASE; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PATIENT MONITORING; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROCTOCOLECTOMY; PROSPECTIVE STUDY; PROTEIN INDUCTION; TISSUE REPAIR; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; PROCTOCOLECTOMY, RESTORATIVE; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TENASCIN;

EID: 0034805456     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003840100312     Document Type: Article

References (31)

1. Tenascin: An extracellular matrix protein prominent in specialized embryonic tissues and tumors
2. The tenascin gene family - Versatile glycoproteins implicated in neural pattern formation and regeneration
3. Comparative analysis of the expression of the extracellular matrix protein tenascin in normal fetal, adult and tumor tissues
4. Tenascin in normal, reactive, hyperplastic, and neoplastic tissues
5. Tenascin in inflammatory conditions and neoplasms of the urinary bladder
6. Tenascin expression in inflammatory, dysplastic and neoplastic lesions of the human stomach
7. Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast
8. Tenascin expression in human chronic liver disease and in hepatocellular carcinoma
9. Appearance of the myofibroblastic phenotype in Dupuytren's disease is associated with a fibronectin, laminin, collagen type IV and tenascin extracellular matrix
10. Tenascin-C promotes healing of habu-snake venom-induced glomerulonephritis
11. Tenascin during gut development: Appearance in the mesenchyme, shift in molecular forms, and dependence on epithelial-mesenchymal interactions
12. Expression of tenascin in the developing human small intestine
13. Altered content and distribution of tenascin in colitis, colon adenoma, and colorectal carcinoma
14. Mucosal tenascin C content in inflammatory and neoplastic diseases of the large bowel
15. Deficiency of epithelial basement membrane laminin in ulcerative colitis affected human colonic mucosa
16. Etiology of the inflammatory bowel diseases
17. Localization and quantitation of hexabrachion (tenascin) in skin, embryonic brain, tumors, and plasma
18. Characterisation of tenascin secreted by human melanoma cells
19. Determination of tenascin in human serum by use of a new enzyme immunoassay
20. Development and application of an enzyme immunoassay for tenascin
21. Enzyme immunoassay for quantification of tenascin in biologic samples
22. Significance of tenascin serum level as tumor marker in primary colorectal carcinoma
23. Tenascin-C in serum: A questionable tumor marker
24. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: A randomised trial
25. Development of Crohn's disease development index
26. J1/Tenascin is a repulsive substrate for central nervous system neurons
27. Biopsy studies in ulcerative colitis
28. Cortisone in ulcerative colitis
29. A role for transcription factor NF-kB in intestinal inflammation
30. Liver involvement in patients operated for ulcerative colitis, with special reference to the association of cholangitis with colorectal dysplasia and carcinoma
31. Cholangitis in ulcerative colitis - A risk factor for colonic malignancy?